Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for preventing and curing laryngolaryngitis and its preparation method

A technology of throat inflammation and medicine, which is applied in the field of pure traditional Chinese medicine for treating pharyngitis and its preparation. It can solve the problems of ineffective treatment of pharyngitis, weak effect of pharyngitis and systemic treatment, and unsatisfactory antibacterial and anti-inflammatory effects. Good functional recovery, increased secretion of saliva and salivary protein, and improved microcirculation

Active Publication Date: 2005-01-05
JIANMIN PHARMA GRP CO LTD
View PDF1 Cites 17 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Western medicine throat lozenges are mostly antibiotics and sulfonamide anti-inflammatory drugs, mainly containing quinchloramide, chlorethidium hydrochloride, cedi iodine, etc., which have the effect of local disinfection and sterilization, and the effect is single, and the effect on pharyngitis and systemic treatment is weak
The candy throat lozenges currently on the market are mainly composed of green fruit, Luo Han Guo and a large amount of peppermint oil and eucalyptus oil, which are mainly local cooling and have no effect on the treatment of pharyngitis.
The invention patent application with publication number CN1456344A and publication date of November 19, 2003 discloses a pharmaceutical composition for treating pharyngitis and a preparation method thereof, which can rapidly relieve symptoms such as sore throat and dry noise, but its antibacterial Anti-inflammatory effect is not ideal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0056] Scrophulariae 5 Ophiopogon japonicus 3 Cicada slough 2 Myrobalan 3 Bellflower 3

[0057] Banlangen 3 fat sea 2 habitat 5 licorice 1 green fruit 1

[0058] The production method is as follows: the combined medicine of the above formula is added with 6 times of the total amount of medicinal materials and decocted for 4 times, the filtrate is collected respectively, and the filtrate is left to settle for 24 hours, and the supernatant is taken; the above supernatants are combined and concentrated to The relative density is 1.33 (20°C), then fully mixed with powdered sugar, starch and sodium carboxymethyl cellulose, granulated, batched, and tabletted to obtain the product.

Embodiment 2

[0060] Scrophulariae 40, Ophiopogon japonicus 20, Cicada slough 10 Myrobalan 20, Campanulaceae 20

[0061] Banlangen 20 Panghaihai 2 Habitat 40 Licorice 2 Green Fruit 6

[0062] The production method is as follows: the combined medicine of the above formula is added with 12 times of the total amount of medicinal materials and decocted twice, the filtrate is collected respectively, and the filtrate is left to settle for 12 hours, and the supernatant is taken; the above supernatants are combined and concentrated to The relative density is 1.34 (20°C), then fully mixed with powdered sugar, sorbitol, and starch, granulated, added peppermint oil as ingredients, and pressed into tablets to obtain the product.

Embodiment 3

[0064] Scrophulariaceae 10 Ophiopogon japonicus 7 Cicada slough 4 Myrobalan 3 Bellflower 5

[0065] Banlangen 5 fat sea 1 raw land 5 licorice 2 green fruit 3

[0066] The production method is as follows: the combined medicine of the above formula is added with 10 times of the total amount of medicinal materials and decocted twice, the filtrate is collected respectively, and the filtrate is left to settle for 20 hours, and the supernatant is taken; the above supernatants are combined and concentrated to The relative density is 1.32 (20°C), then fully mixed with powdered sugar and xylitol, granulated, dried, and added with fruit flavor ingredients to obtain granules.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A Chinese medicine for treating laryngolaryngitis and upper respiratory tract inflammation is prepared from 10 Chinese-medicinal materials including scrophularia root, ophiopogon root, ciccada slough, myrobalan seed, etc through proportionally mixing, extracting and mixing with sugar or syrup and additive.

Description

technical field [0001] The present invention relates to a kind of pure traditional Chinese medicine medicine and preparation method for treating pharyngitis, specifically [0002] A medicine for preventing and treating throat diseases with health care and treatment functions and a preparation method thereof. Background technique [0003] Pharyngitis is a common multiple upper respiratory tract infection, which seriously affects people's normal life and social interaction. If it is not treated in time, it can induce other diseases, such as acute rhinitis, acute sinusitis, acute tonsillitis, and pulmonary infection. etc. Acute pharyngitis treatment is not timely and incomplete, and repeated attacks will turn into chronic pharyngitis, neck radiation therapy or other physical and chemical stimulation, various chronic diseases such as anemia, constipation, chronic inflammation of the lower respiratory tract, cardiovascular disease, etc. Can secondary chro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/12A61K35/64A61P11/04
Inventor 陈立明孙桂芝夏国强胡上达雷艳明易慧琳
Owner JIANMIN PHARMA GRP CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products